Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

STRO Stock Annual Income Statement. Download in Excel

Sutro Biopharma Inc. logo

Sutro Biopharma Inc.

Sector: Healthcare   

Industry: Biotechnology

1.88
 
USD
  
0.06
  
(3.30%)
Previous close: 1.82  Open: 1.79  Bid: 1.9  Ask: 1.95
52 week range    
1.70   
   6.13
Mkt Cap: 172 M  Avg Vol (90 Days): 862,787
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Sunday 22nd December 2024

Stock Rankings

44
MarketXLS Rank
60
Value
30
Technical
42
Quality
How are these ranks calculated?
Search for a stock

Financials

STRO Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.43-0.99-2.29-2.35-1.78
Basic EPS total-2.43-0.99-2.29-2.35-1.78
Basic weighted shares outstanding6 M23 M33 M46 M51 M60 M
Depreciation4 M5 M6 M7 M
DepreciationAndAmortization4 M5 M6 M7 M
Diluted EPS total-6.13-2.43-0.99-2.29-2.35-1.78
Diluted normalized net income/share-2.35-1.78
Diluted weighted shares outstanding7 M23 M33 M51 M60 M
GainOnSaleOfSecurity2 M4 M2 M577000.03 M15 M
GeneralAndAdministrativeExpense21 M33 M37 M56 M60 M63 M
Gross operating profit38 M43 M43 M62 M68 M154 M
Income before tax-36 M-51 M-28 M-106 M-117 M-89 M
Income taxes103000.03 M18 M
InterestExpenseNonOperating-2 M1 M4 M3 M3 M24 M
MiscOtherSpecialCharges2 M49 M
Net income from total operations-35 M-56 M-32 M-106 M-119 M-107 M
NetIncomeCommonStockholders-35 M-56 M-32 M-106 M-119 M-107 M
NetIncomeContinuousOperations-35 M-56 M-32 M-106 M-119 M-107 M
NetIncomeFromOtherGainsLosses290000.0-4 M-4 M-3 M
NetNonOperatingInterestIncomeExpense2 M-1 M-2 M-3 M-109000.09 M
Normalized income-70 M
Operating income-37 M-55 M-71 M-99 M-129 M-89 M
Operating income before depreciation (EBITDA)-33 M-47 M-24 M-98 M-108 M-58 M
OperatingExpense-76 M98 M114 M160 M197 M243 M
Other income net-2 M-4 M-43 M4 M12 M10 M
OtherGandA21 M33 M37 M56 M60 M63 M
OtherOperatingExpenses-741000.0-1 M-1 M-1 M-2 M-3 M
RentAndLandingFees21 M3600.05 M
Research & development expense54 M66 M77 M104 M137 M180 M
ResearchExpense54 M66 M77 M104 M137 M180 M
Revenue per share200000.0500000.0600000.0500000.0300000.0
SalariesAndWages-3 M
Selling Gen & administrative expense21 M33 M37 M56 M60 M63 M
Total Income available for interest expense (EBIT)-37 M-50 M-28 M-102 M-113 M-65 M
Total common shares outstanding23 M23 M46 M46 M60 M62 M
Total net income-35 M-56 M-32 M-106 M-119 M-107 M
Total ordinary shares82 M82 M82 M82 M82 M82 M
Total revenues38 M43 M43 M62 M68 M154 M
TotalExpenses-76 M98 M114 M160 M197 M243 M
TotalRevenue38 M43 M43 M62 M68 M154 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University